Serratus Plane Block Versus Serratus Plane Block Plus Parasternal Block Combination for Breast Surgery
1 other identifier
interventional
64
1 country
1
Brief Summary
Mastectomy is a technique often used in breast cancer surgery. Patients experience moderate to severe pain postoperatively after this procedure. Various plane blocks, NSAIDs, and opioid analgesics can be administered to these patients as components of multimodal analgesia. In the the study, the investigators aimed to evaluate the analgesic effects of the serratus plane block, the parasternal block added to the serratus plane block, and the dermatomal differences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2023
CompletedStudy Start
First participant enrolled
June 21, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2024
CompletedApril 1, 2024
March 1, 2024
6 months
May 30, 2023
March 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative opioid consumption
First 24 hours total fentanyl consumption with patient controlled analgesia
first 24 hours
Secondary Outcomes (2)
Visual analog pain score
First 24 hours
Sensory Assessment
24 hours
Study Arms (2)
group serratus
PLACEBO COMPARATORpreoperative superficial serratus block with local anaesthetics and parasternal block with saline
group serratus and parasternal
ACTIVE COMPARATORpreoperative superficial serratus block and parasternal block with local anaesthetics
Interventions
preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml saline
preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml %0.25 Bupivacaine
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologist's physiologic state I-III patients
- To undergo Mastectomy Surgery
- Being between the ages of 18-65 years
You may not qualify if:
- Having a known heart, kidney, liver or hematological disease
- Having a history of peptic ulcer, gastrointestinal bleeding, allergy, chronic pain
- Routine analgesic use and history of analgesic use in the last 24 hours
- Not willing to participate in the study
- Uncooperative patients who have coagulopathy or use anticoagulant drugs
- To be allergic to one of the drugs to be used
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ali Ahiskalioglu
Erzurum, 25100, Turkey (Türkiye)
Related Publications (2)
Hu NQ, He QQ, Qian L, Zhu JH. Efficacy of Ultrasound-Guided Serratus Anterior Plane Block for Postoperative Analgesia in Patients Undergoing Breast Surgery: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Pain Res Manag. 2021 Oct 25;2021:7849623. doi: 10.1155/2021/7849623. eCollection 2021.
PMID: 34733377BACKGROUNDPiraccini E, Biondi G, Corso RM, Maitan S. The use of rhomboid intercostal block, parasternal block and erector spinae plane block for breast surgery. J Clin Anesth. 2020 Feb;59:10. doi: 10.1016/j.jclinane.2019.06.004. Epub 2019 Jun 6. No abstract available.
PMID: 31176954BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hüsnü Kürşad
Ataturk University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 30, 2023
First Posted
June 22, 2023
Study Start
June 21, 2023
Primary Completion
January 1, 2024
Study Completion
January 15, 2024
Last Updated
April 1, 2024
Record last verified: 2024-03